MUENCHEN
Germany
27
2026-01-22
The entities that hold a legal rights for patent applications filed by inventor MOLHOJ MICHAEL:
MICHAEL MOLHOJ from MUENCHEN, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
#2 | 2024-09-26BISPECIFIC ANTI-HUMAN CD20/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE
#3 | 2024-05-02BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
#4 | 2023-09-14BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
#5 | 2023-08-24Humanized anti-Tau(PS422) antibodies and methods of use
#6 | 2022-12-22BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
#7 | 2022-09-29Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
#8 | 2021-10-07MULTISPECIFIC ANTIBODIES
#9 | 2021-07-01Direct affinity measurement of human IgG1 binding multimeric antigens
#10 | 2021-07-01Method for determining the in vivo interaction mode
#11 | 2021-05-13Humanized anti-Tau(pS422) antibodies and methods of use
#12 | 2020-07-23Bispecific T cell activating antigen binding molecules
#13 | 2020-04-02Method for detecting multispecific antibody light chain mispairing
#14 | 2019-01-17DIRECT AFFINITY MEASUREMENT OF HUMAN IGG1 BINDING MULTIMERIC ANTIGENS
#15 | 2019-01-17METHOD FOR DETERMINING THE IN VIVO INTERACTION MODE
#16 | 2018-08-09Bispecific T cell activating antigen binding molecules
#17 | 2018-08-09Bispecific T cell activating antigen binding molecules
#18 | 2018-03-22Humanized anti-tau(pS422) antibodies and methods of use
#19 | 2017-10-26BISPECIFIC ANTIBODIES AGAINST CD3EPSILON AND ROR1 FOR USE IN THE TREATMENT OF OVARIAN CANCER
#20 | 2017-10-26Bispecific antibodies against CD3ϵ and BCMA
#21 | 2017-10-26Bispecific antibodies against CD3EPSILON and ROR1
#22 | 2017-08-31Anti-ANG2 antibodies and methods of use
#23 | 2017-08-24Bispecific antibodies and methods of use in ophthalmology
#24 | 2017-04-27METHOD FOR DETECTING MULTISPECIFIC ANTIBODY LIGHT CHAIN MISPAIRING
#25 | 2016-12-29Humanized anti-tau(pS422) antibodies and methods of use
#26 | 2016-03-17Bispecific T cell activating antigen binding molecules
#27 | 2015-11-05MULTISPECIFIC ANTIBODIES
1346038 ⎘